BlackRock Inc. - INNATE PHARMA S A ownership

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 14 filers reported holding INNATE PHARMA S A in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2022$965,000
-28.1%
482,645
-2.9%
0.00%
Q2 2022$1,343,000
-20.8%
497,275
-1.4%
0.00%
Q1 2022$1,695,000
-6.1%
504,408
+27.4%
0.00%
Q4 2021$1,806,000396,0730.00%
Other shareholders
INNATE PHARMA S A shareholders Q1 2022
NameSharesValueWeighting ↓
Rubric Capital Management LP 931,673$6,382,0000.73%
ADAGE CAPITAL PARTNERS GP, L.L.C. 500,000$3,425,0000.01%
WELLINGTON MANAGEMENT GROUP LLP 1,351,538$9,866,0000.00%
MILLENNIUM MANAGEMENT LLC 72,657$530,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 12,441$85,0000.00%
Steward Partners Investment Advisory, LLC 1,100$8,0000.00%
OSAIC HOLDINGS, INC. 2,000$14,0000.00%
View complete list of INNATE PHARMA S A shareholders